Association between rituximab treatment and outcome in nonparaneoplastic autoimmune cerebellar ataxia: an observational cohort study
BackgroundAutoimmune cerebellar ataxia (ACA) can cause substantial disability. Evidence regarding immunotherapy for ACA, including rituximab (RTX), remains limited. This study evaluated the association of RTX treatment with outcomes in nonparaneoplasti…